Cargando…

Incidence of cervical precancerous lesions and cervical cancer in Denmark from 2000 to 2019: Population impact of multi‐cohort vaccination against human papillomavirus infection

In Denmark, vaccination against human papillomavirus (HPV) has been implemented in the children's vaccination program (January 2009) and in multiple catch‐up cohorts (October 2008 in girls 13‐15 years and in August 2012 in women up to 27 years). In the present study we estimate incidence of cer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ring, Linea Landgrebe, Munk, Christian, Galanakis, Michael, Tota, Joseph E., Thomsen, Louise T., Kjaer, Susanne K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Cancer Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092791/ https://www.ncbi.nlm.nih.gov/pubmed/36250312 http://dx.doi.org/10.1002/ijc.34328

Ejemplares similares

Comparison of human papillomavirus‐based cervical cancer screening strategies in Tanzania among women with and without HIV
por: Kahesa, Crispin, et al.
Publicado: (2022)

Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016
por: Orumaa, Madleen, et al.
Publicado: (2019)

Impact of HPV vaccination on outcome of cervical cytology screening in Denmark—A register‐based cohort study
por: Thamsborg, Lise Holst, et al.
Publicado: (2018)

Human papillomavirus self‐sampling for screening nonattenders: Opt‐in pilot implementation with electronic communication platforms
por: Lam, Janni Uyen Hoa, et al.
Publicado: (2017)

Human papillomavirus types in cervical high‐grade lesions or cancer among Nordic women—Potential for prevention
por: Dovey de la Cour, Cecilie, et al.
Publicado: (2019)

Risk of nonovarian cancer in a nationwide‐based study of nearly 5000 women with borderline ovarian tumors in Denmark
por: Hannibal, Charlotte G., et al.
Publicado: (2022)

Role of human papillomavirus status after conization for high‐grade cervical intraepithelial neoplasia
por: Huang, Huei‐Jean, et al.
Publicado: (2020)

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer
por: Inturrisi, Federica, et al.
Publicado: (2020)

Long‐term survival of nonlocalized epithelial ovarian cancer among women using menopausal hormone therapy prior to diagnosis: The extreme study
por: Baandrup, Louise, et al.
Publicado: (2022)

Human papillomavirus genotypes in cervical and other HPV‐related anogenital cancer in Rwanda, according to HIV status
por: Mpunga, Tharcisse, et al.
Publicado: (2019)

A cervical screening initiative for elderly women in Denmark
por: Skorstengaard, Malene, et al.
Publicado: (2023)

The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost‐effectiveness of human papillomavirus screening with self‐collection and digital registry support
por: Keane, Adam, et al.
Publicado: (2021)

Clinical Performance of Human Papillomavirus (HPV) Testing versus Cytology for Cervical Cancer Screening: Results of a Large Danish Implementation Study
por: Thomsen, Louise T, et al.
Publicado: (2020)

The relative risk of noncervical high‐risk human papillomavirus‐related (pre)malignancies after recurrent cervical intraepithelial neoplasia grade 3: A population‐based study
por: Loopik, Diede L., et al.
Publicado: (2019)

Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya
por: De Vuyst, H, et al.
Publicado: (2012)

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders
por: Lam, J U H, et al.
Publicado: (2018)

Cervical cancer case–control audit: Results from routine evaluation of a nationwide cervical screening program
por: Wang, Jiangrong, et al.
Publicado: (2019)

Human papillomavirus genotype-specific risks for cervical intraepithelial lesions
por: Nygård, Mari, et al.
Publicado: (2020)

Efficacy of careHPV™ human papillomavirus screening versus conventional cytology tests for the detection of precancerous and cancerous cervical lesions among women living with HIV‐1 in Lao People's Democratic Republic
por: Paboriboune, Phimpha, et al.
Publicado: (2022)

Distribution of human papillomavirus in precancerous and cancerous cervical neoplasia in Tunisian women
por: Bel Haj Rhouma, Rahima, et al.
Publicado: (2021)

Human papillomavirus genotypes associated with cervical precancerous lesions and cancer in the highest area of cervical cancer mortality, Longnan, China
por: Zhao, Jin, et al.
Publicado: (2017)

Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
por: Castanon, Alejandra, et al.
Publicado: (2016)

Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up
por: Jensen, K E, et al.
Publicado: (2013)

Differences in the risk of cervical cancer and human papillomavirus infection by education level
por: Franceschi, S, et al.
Publicado: (2009)

Raman spectroscopic study of cervical precancerous lesions and cervical cancer
por: Wang, Jing, et al.
Publicado: (2021)

Quadrivalent HPV vaccine effectiveness against high‐grade cervical lesions by age at vaccination: A population‐based study
por: Herweijer, Eva, et al.
Publicado: (2016)

miRNAs signature as potential biomarkers for cervical precancerous lesions in human papillomavirus positive women
por: González-Ramírez, Martha I., et al.
Publicado: (2023)

Cervical Microbiome and Response to a Human Papillomavirus Therapeutic Vaccine for Treating High-Grade Cervical Squamous Intraepithelial Lesion
por: Ravilla, Rahul, et al.
Publicado: (2019)

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
por: Clifford, G M, et al.
Publicado: (2003)

Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway
por: Burger, E A, et al.
Publicado: (2012)

Perspectives of Screening‐Eligible Women and Male Partners on Benefits of and Barriers to Treatment for Precancerous Lesions and Cervical Cancer in Kenya
por: Ragan, Kathleen R., et al.
Publicado: (2017)

Methylation of CpG 5962 in L1 of the human papillomavirus 16 genome as a potential predictive marker for viral persistence: A prospective large cohort study using cervical swab samples
por: Fertey, Jasmin, et al.
Publicado: (2019)

Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology
por: Wall, S R, et al.
Publicado: (2005)

Human papillomavirus infection in women who develop high-grade cervical intraepithelial neoplasia or cervical cancer: a case–control study in the UK
por: Grainge, M J, et al.
Publicado: (2005)

Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
por: van Rosmalen, J, et al.
Publicado: (2012)

Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays
por: Rebolj, Matejka, et al.
Publicado: (2016)

Human papillomavirus (HPV) testing for cervical cancer screening in a middle-income country: comment on a large real-world implementation study in China
por: Thomsen, Louise T., et al.
Publicado: (2021)

Prevalence characteristics of high-risk human papillomaviruses in women living in Shanghai with cervical precancerous lesions and cancer
por: Gu, Ying, et al.
Publicado: (2016)

Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis
por: Campos, Nicole G., et al.
Publicado: (2018)

Ki-67 and P16 proteins in cervical cancer and precancerous lesions of young women and the diagnostic value for cervical cancer and precancerous lesions
por: Shi, Qin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g4rc6rfv5a1etvqvocde0hkak9